Kevin Bruhn

VP, Clinical Development at Bexson Biomedical

Kevin is a PhD scientist with a background in developing novel therapies for patients. He has over 15 years of experience in basic and translational research in the fields of infectious disease, cancer immunotherapy, and vaccine development. Most recently Kevin spent over 5 years in the rapidly expanding area of decentralized clinical trials, working with both small and large drug development companies to employ new strategies to enhance trial efficacy. Kevin received his bachelor’s degree from the University of Pennsylvania, and his PhD in Microbiology, Immunology and Molecular Genetics from UCLA.

Links

Timeline

  • VP, Clinical Development

    May, 2021 - present

View in org chart